Lancet study warns AI and nuclear war could end humanity by 2100

By Splitfeed EditorialLast updated Oct 12, 2026, 17:30 UTC

The Lancet, one of the oldest peer-reviewed medical journals in the world, published an assessment in October 2026 warning that nuclear war, the malicious use of artificial intelligence, and bioweapons represent credible existential threats to humanity before the year 2100. The report does not treat AI as a standalone danger but groups it with nuclear and biological weapons as part of a cluster of civilisation-scale risks. The journal's framing places this squarely in the domain of public health rather than speculative futurism, which is significant given The Lancet's standing in scientific and policy circles.

The institutional weight of the source is what separates this from routine AI doom discourse. When a journal of The Lancet's reputation applies its peer-review process to existential risk, the claim carries a different kind of authority than a think-tank paper or a tech-industry warning. What is genuinely in dispute is the mechanism and probability: the report names malicious use of AI as a threat, but critics and supporters of that framing will disagree sharply about how plausible that pathway is, how soon it becomes relevant, and whether grouping AI with nuclear weapons is analytically sound or rhetorically misleading.

No reactions from the Pro-AI, Anti-AI, or Middle Ground camps had been published at the time of writing. The Pro-AI camp would typically argue that the risks of AI misuse are manageable through governance and that conflating AI with nuclear weapons overstates the danger while understating the life-saving potential of the technology. The Anti-AI camp would likely welcome the Lancet's framing as long-overdue mainstream validation of concerns that critics of AI development have raised for years. The Middle Ground camp would probably focus on the specific conditions under which malicious AI use becomes catastrophic, calling for targeted policy rather than broad alarm.

The argument is unlikely to be settled by a single publication, but future indicators worth tracking include whether policymakers cite the Lancet assessment in legislative or treaty contexts, and whether follow-up peer-reviewed responses challenge or support its methodology for estimating existential risk probabilities.